OBESITY, COMORBIDITIES, AND ECONOMIC EVALUATIONS OF SURGICAL TREATMENTS OF OBESIT

肥胖、合并症和肥胖手术治疗的经济评估

基本信息

  • 批准号:
    9144338
  • 负责人:
  • 金额:
    $ 13.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-30 至 2017-09-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The prevalence of overweight and obesity is increasing globally, which is thought to account for a substantial number of chronic diseases and cancers. Surgical treatment of obesity has been shown to be effective in long- term weight control, provide additional benefits to people with obesity-related diseases, and reduce relative risk of death. However, it is not universally available to all classes of obese people. The proposed research will closely examine the costs and effectiveness of bariatric surgery. The ultimate goal is to examine the appropriateness of current NIH guidelines and to inform insurance companies, patients, providers, and the government of the most cost-effective surgical treatment of obesity. The Research Specific Aims are to (1) examine the association between obesity, obesity-related comorbidities, and mortality; (2) evaluate the safety and effectiveness of bariatric surgery; (3) investigate the costs attributable to obesity-related diseases; and (4) conduct cost-consequence analyses of bariatric surgery. The research methodology includes econometric modeling (Research Specific Aim 1 and 3), meta-analysis (Research Specific Aim 2), microsimulation (Research Specific Aim 3 and 4), and cost-effectiveness analysis (Research Specific Aim 4). In order to successfully complete the proposed research, this project will also provide the applicant with mentoring by three experts who, in conjunction with didactic training, will enable the applicant to grow into an effective and independent health services research investigator and health economist in obesity prevention and control. The mentoring team and the applicant have worked together and identified three Career Development Aims: (1) to become an independent and externally-funded researcher; (2) to obtain working knowledge of obesity epidemiology and gastroenterology; (3) to enhance the quality of research by obtaining training in the areas of public health and quantitative modeling. These aims will be achieved through a variety of training strategies, including regular one-on-one meetings with each of three mentors who are experts in the relevant domains, didactic coursework, high-quality online training modules, and attendance at scientific conferences and workshops. The proposed research will provide preliminary data and results for several R21 and an R01 or equivalent applications. These projects will expand to examine other interventions to control obesity, e.g., exercise, diet, medications, and surgery and will be compared within a metric of intensity; alternatively, these projects will examine the relationship between obesity and cancer and how interventions to control obesity can alter this relationship.
描述(由申请人提供):超重和肥胖的患病率在全球范围内不断增加,这被认为是导致大量慢性疾病和癌症的原因。肥胖症的手术治疗已被证明在长期体重控制中是有效的,为患有肥胖相关疾病的人提供额外的益处,并降低死亡的相对风险。然而,它并不是普遍适用于所有类型的肥胖人群。这项拟议中的研究将密切关注减肥手术的成本和有效性。最终目标是检查当前NIH指南的适当性,并告知保险公司,患者,供应商和政府最具成本效益的肥胖手术治疗。研究的具体目的是(1)检查肥胖、肥胖相关合并症和死亡率之间的关系;(2)评价减肥手术的安全性和有效性;(3)调查肥胖相关疾病的成本;(4)进行减肥手术的成本-后果分析。研究方法包括计量经济学建模(研究特定目标1和3),荟萃分析(研究特定目标2),微观模拟(研究特定目标3和4)和成本效益分析(研究特定目标4)。为了成功完成拟议的研究,该项目还将为申请人提供三位专家的指导,他们与教学培训相结合,将使申请人成长为一个有效的, 肥胖预防和控制方面的独立卫生服务研究调查员和卫生经济学家。指导团队和申请人共同努力,确定了三个职业发展目标:(1)成为一名独立的外部资助研究人员;(2)获得肥胖流行病学和胃肠病学的工作知识;(3)通过获得公共卫生和定量建模领域的培训来提高研究质量。这些目标将通过各种培训战略来实现,包括与三名导师(他们是相关领域的专家)定期举行一对一会议,教学课程,高质量的在线培训模块,以及参加科学会议和研讨会。拟议的研究将为几个R21和R 01或同等应用提供初步数据和结果。这些项目将扩大到研究控制肥胖的其他干预措施,例如,运动、饮食、药物和手术,并将在一个强度指标内进行比较;或者,这些项目将研究肥胖和癌症之间的关系,以及控制肥胖的干预措施如何改变这种关系。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Su-Hsin Chang其他文献

Su-Hsin Chang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Su-Hsin Chang', 18)}}的其他基金

Addressing racial disparities in monoclonal gammopathy of undetermined significance and progression to multiple myeloma from a prevention perspective
从预防角度解决意义不明的单克隆丙种球蛋白病的种族差异以及多发性骨髓瘤的进展
  • 批准号:
    10442544
  • 财政年份:
    2020
  • 资助金额:
    $ 13.67万
  • 项目类别:
Addressing racial disparities in monoclonal gammopathy of undetermined significance and progression to multiple myeloma from a prevention perspective
从预防角度解决意义不明的单克隆丙种球蛋白病的种族差异以及多发性骨髓瘤的进展
  • 批准号:
    10055834
  • 财政年份:
    2020
  • 资助金额:
    $ 13.67万
  • 项目类别:
Addressing racial disparities in monoclonal gammopathy of undetermined significance and progression to multiple myeloma from a prevention perspective
从预防角度解决意义不明的单克隆丙种球蛋白病的种族差异以及多发性骨髓瘤的进展
  • 批准号:
    10271266
  • 财政年份:
    2020
  • 资助金额:
    $ 13.67万
  • 项目类别:
MODELING THE COEXISTENCE OF CHRONIC DISEASES RELATED TO OBESITY
模拟与肥胖相关的慢性疾病的共存
  • 批准号:
    9316055
  • 财政年份:
    2017
  • 资助金额:
    $ 13.67万
  • 项目类别:
OBESITY, COMORBIDITIES, AND ECONOMIC EVALUATIONS OF SURGICAL TREATMENTS OF OBESIT
肥胖、合并症和肥胖手术治疗的经济评估
  • 批准号:
    8566961
  • 财政年份:
    2013
  • 资助金额:
    $ 13.67万
  • 项目类别:
OBESITY, COMORBIDITIES, AND ECONOMIC EVALUATIONS OF SURGICAL TREATMENTS OF OBESIT
肥胖、合并症和肥胖手术治疗的经济评估
  • 批准号:
    8733512
  • 财政年份:
    2013
  • 资助金额:
    $ 13.67万
  • 项目类别:

相似海外基金

Development and Translation Mass Spectrometry Methods to Determine BioMarkers for Parkinson's Disease and Comorbidities
确定帕金森病和合并症生物标志物的质谱方法的开发和转化
  • 批准号:
    2907463
  • 财政年份:
    2024
  • 资助金额:
    $ 13.67万
  • 项目类别:
    Studentship
Multi-omic signatures of gut dysbiosis and cardiovascular comorbidities associated with HIV infection
与 HIV 感染相关的肠道菌群失调和心血管合并症的多组学特征
  • 批准号:
    10762411
  • 财政年份:
    2023
  • 资助金额:
    $ 13.67万
  • 项目类别:
Addressing Dental and Psychiatric Comorbidities: Screening and Referrals of HIV/AIDS Patients
解决牙科和精神合并症:艾滋病毒/艾滋病患者的筛查和转诊
  • 批准号:
    10671164
  • 财政年份:
    2023
  • 资助金额:
    $ 13.67万
  • 项目类别:
Effect of stage at diagnosis, treatment, and physical comorbidities on mortality following cancer diagnosis among people with non-affective psychotic disorders: A causal mediation analysis
诊断、治疗和身体合并症的分期对非情感性精神障碍患者癌症诊断后死亡率的影响:因果中介分析
  • 批准号:
    495238
  • 财政年份:
    2023
  • 资助金额:
    $ 13.67万
  • 项目类别:
Understanding cancer and comorbidities among American Indian and Alaska Native people
了解美洲印第安人和阿拉斯加原住民的癌症和合并症
  • 批准号:
    10722119
  • 财政年份:
    2023
  • 资助金额:
    $ 13.67万
  • 项目类别:
Building Research Capacity to Study Periodontitis and Associated Systemic Comorbidities in the Caribbean
建设加勒比地区牙周炎及相关系统合并症的研究能力
  • 批准号:
    10664397
  • 财政年份:
    2023
  • 资助金额:
    $ 13.67万
  • 项目类别:
Mechanisms of human appendicular and cardiovascular comorbidities: An analysis of heterogeneity and lineage trajectories of the lateral plate mesoderm
人类四肢和心血管合并症的机制:侧板中胚层的异质性和谱系轨迹分析
  • 批准号:
    10642590
  • 财政年份:
    2023
  • 资助金额:
    $ 13.67万
  • 项目类别:
Defining a Stage-Based Framework of Comorbidities among Children with Severe Neurologic Impairment
定义严重神经损伤儿童合并症的阶段性框架
  • 批准号:
    479359
  • 财政年份:
    2023
  • 资助金额:
    $ 13.67万
  • 项目类别:
    Operating Grants
Epigenetic and molecular regulation of aging and age-related comorbidities
衰老和年龄相关合并症的表观遗传和分子调控
  • 批准号:
    491111
  • 财政年份:
    2023
  • 资助金额:
    $ 13.67万
  • 项目类别:
    Fellowship Programs
Combined effects of genetic risk and brain insulin-responsive gene networks on psychiatric and metabolic comorbidities in the Canadian Longitudinal Study in Aging (CLSA)
加拿大老龄化纵向研究 (CLSA) 中遗传风险和大脑胰岛素反应基因网络对精神和代谢合并症的综合影响
  • 批准号:
    491782
  • 财政年份:
    2023
  • 资助金额:
    $ 13.67万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了